title: Management of coronary artery disease in end-stage renal disease.
abstract: Despite a substantial number of patients with end-stage renal disease who have coronary artery disease, the comparative effectiveness of revascularization procedures such as coronary artery bypass grafting and percutaneous coronary intervention remain unclear. Innovations in the field of coronary artery revascularization and concomitant changes in the standard of practice have improved outcomes in general. However, meaningful clinical decision-making remains difficult because it requires clinicians to extrapolate evidence derived from studies in the general population to patients with kidney disease for whom there is limited information from intervention trials. In non-randomized studies, this high-risk population for cardiovascular morbidity and mortality appear to derive substantial benefits from coronary revascularization. However, specific treatment decisions are often made based upon individual circumstances and contexts that are not well captured in these studies. This article reviews the available evidence, and its limitations, for deciding between various revascularization strategies for patients with end-stage renal disease. Several considerations that arise while making such decisions are discussed.
authors: Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
authors: John K
authors: JK
authors: Roberts
authors: Uptal D
authors: UD
authors: Patel
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D050197:Atherosclerosis / Q000150:complications; D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000150:complications* / Q000628:therapy*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D008875:Middle Aged; D012307:Risk Factors